124 related articles for article (PubMed ID: 24374861)
1. Proline-rich acidic protein 1 (PRAP1) is a novel interacting partner of MAD1 and has a suppressive role in mitotic checkpoint signalling in hepatocellular carcinoma.
Sze KM; Chu GK; Mak QH; Lee JM; Ng IO
J Pathol; 2014 May; 233(1):51-60. PubMed ID: 24374861
[TBL] [Abstract][Full Text] [Related]
2. Role of a novel splice variant of mitotic arrest deficient 1 (MAD1), MAD1beta, in mitotic checkpoint control in liver cancer.
Sze KM; Ching YP; Jin DY; Ng IO
Cancer Res; 2008 Nov; 68(22):9194-201. PubMed ID: 19010891
[TBL] [Abstract][Full Text] [Related]
3. Mitotic checkpoint gene MAD1 in hepatocellular carcinoma is associated with tumor recurrence after surgical resection.
Nam CW; Park NH; Park BR; Shin JW; Jung SW; Na YW; Seo JH
J Surg Oncol; 2008 Jun; 97(7):567-71. PubMed ID: 18491369
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
5. Proline-rich acidic protein 1 upregulates mitotic arrest deficient 1 to promote cisplatin-resistance of colorectal carcinoma by restraining mitotic checkpoint complex assembly.
Song J; Chen Y; Yu H; Zheng L; Wang Y; Li D
J Cancer; 2023; 14(9):1515-1530. PubMed ID: 37325046
[No Abstract] [Full Text] [Related]
6. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
7. The Mad1-Mad2 balancing act--a damaged spindle checkpoint in chromosome instability and cancer.
Schuyler SC; Wu YF; Kuan VJ
J Cell Sci; 2012 Sep; 125(Pt 18):4197-206. PubMed ID: 23093575
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis.
Jeong SJ; Shin HJ; Kim SJ; Ha GH; Cho BI; Baek KH; Kim CM; Lee CW
Cancer Res; 2004 Dec; 64(23):8666-73. PubMed ID: 15574775
[TBL] [Abstract][Full Text] [Related]
9. Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol.
Kienitz A; Vogel C; Morales I; Müller R; Bastians H
Oncogene; 2005 Jun; 24(26):4301-10. PubMed ID: 15782113
[TBL] [Abstract][Full Text] [Related]
10. A Golgi-localized pool of the mitotic checkpoint component Mad1 controls integrin secretion and cell migration.
Wan J; Zhu F; Zasadil LM; Yu J; Wang L; Johnson A; Berthier E; Beebe DJ; Audhya A; Weaver BA
Curr Biol; 2014 Nov; 24(22):2687-92. PubMed ID: 25447996
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.
Dai Y; Liu L; Zeng T; Zhu YH; Li J; Chen L; Li Y; Yuan YF; Ma S; Guan XY
Biochem Biophys Res Commun; 2013 Jul; 436(4):711-8. PubMed ID: 23791740
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of p31comet gene, a negative regulator of Mad2, in human hepatocellular carcinoma.
Yun MY; Kim SB; Park S; Han CJ; Han YH; Yoon SH; Kim SH; Kim CM; Choi DW; Cho MH; Park GH; Lee KH
Exp Mol Med; 2007 Aug; 39(4):508-13. PubMed ID: 17934339
[TBL] [Abstract][Full Text] [Related]
14. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
16. ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry.
Zen K; Yasui K; Nakajima T; Zen Y; Zen K; Gen Y; Mitsuyoshi H; Minami M; Mitsufuji S; Tanaka S; Itoh Y; Nakanuma Y; Taniwaki M; Arii S; Okanoue T; Yoshikawa T
Genes Chromosomes Cancer; 2009 Feb; 48(2):109-20. PubMed ID: 18973138
[TBL] [Abstract][Full Text] [Related]
17. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons.
Ryan SD; Britigan EM; Zasadil LM; Witte K; Audhya A; Roopra A; Weaver BA
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):E2205-14. PubMed ID: 22778409
[TBL] [Abstract][Full Text] [Related]
19. HBxAPα/Rsf-1-mediated HBx-hBubR1 interactions regulate the mitotic spindle checkpoint and chromosome instability.
Chae S; Ji JH; Kwon SH; Lee HS; Lim JM; Kang D; Lee CW; Cho H
Carcinogenesis; 2013 Jul; 34(7):1680-8. PubMed ID: 23536579
[TBL] [Abstract][Full Text] [Related]
20. A mitotic role for Mad1 beyond the spindle checkpoint.
Emre D; Terracol R; Poncet A; Rahmani Z; Karess RE
J Cell Sci; 2011 May; 124(Pt 10):1664-71. PubMed ID: 21511728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
